Your browser doesn't support javascript.
loading
Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer.
Healey, Gareth D; Pan-Castillo, Belen; Garcia-Parra, Jezabel; Davies, Julia; Roberts, Shaun; Jones, Eilir; Dhar, Kalyan; Nandanan, Sarika; Tofazzal, Nasima; Piggott, Luke; Clarkson, Richard; Seaton, Gillian; Frostell, Asa; Fagge, Tim; McKee, Colin; Margarit, Lavinia; Conlan, R Steven; Gonzalez, Deyarina.
Afiliação
  • Healey GD; Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
  • Pan-Castillo B; Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
  • Garcia-Parra J; Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
  • Davies J; Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
  • Roberts S; Cellular Pathology Department, Swansea Bay University Health Board, Singleton Hospital, Sketty Lane, Swansea, SA2 8QA, UK.
  • Jones E; Cellular Pathology Department, Swansea Bay University Health Board, Singleton Hospital, Sketty Lane, Swansea, SA2 8QA, UK.
  • Dhar K; Gynecology Oncology Department, Swansea Bay University Health Board, Singleton Hospital, Sketty Lane, Swansea, SA2 8QA, UK.
  • Nandanan S; Obstetrics & Gynecology Department Princess of Wales Hospital, Cwm Taf Morgannwg University Health Board, Coity Road, Bridgend, CF31 1RQ, UK.
  • Tofazzal N; Cellular Pathology Department, Swansea Bay University Health Board, Singleton Hospital, Sketty Lane, Swansea, SA2 8QA, UK.
  • Piggott L; Welsh Cancer Research Centre, Institute of Cancer & Genetics, School of Medicine, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
  • Clarkson R; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK.
  • Seaton G; European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK.
  • Frostell A; GE Healthcare Bio-Sciences, SE-751 84, Uppsala, Sweden.
  • Fagge T; GE Healthcare, Little Chalfont, Buckinghamshire, HP7 9NA, UK.
  • McKee C; ADC Biotechnology Ltd, OpTIC Technium, Ffordd William Morgan, St Asaph Business Park, St Asaph, Denbighshire, LL17 0JD, UK.
  • Margarit L; Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
  • Conlan RS; Obstetrics & Gynecology Department Princess of Wales Hospital, Cwm Taf Morgannwg University Health Board, Coity Road, Bridgend, CF31 1RQ, UK.
  • Gonzalez D; Reproductive Biology and Gynaecological Oncology Group, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
J Immunother Cancer ; 7(1): 280, 2019 10 29.
Article em En | MEDLINE | ID: mdl-31665084
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Imunoconjugados / Receptor para Produtos Finais de Glicação Avançada / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Imunoconjugados / Receptor para Produtos Finais de Glicação Avançada / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article